Novartis AG is 41.6x more valuable than Protagonist Therapeutics, Inc by market capitalization ($282.64 B vs $6.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTGX | NVS |
|---|---|---|
| Market cap | $6.80 B | $282.64 B |
| US-listed rank | #1171 | #47 |
| Revenue (latest FY) | $46.02M | - |
| Net income (latest FY) | -$130.15M | - |
| Net margin | -282.8% | - |
| SEC filings | 668 | 947 |
Novartis AG is 41.6x more valuable than Protagonist Therapeutics, Inc by market capitalization ($282.64 B vs $6.80 B).
Full pages: Protagonist Therapeutics, Inc and Novartis AG, or browse the full rankings.